Location History:
- Boston, MA (US) (2022)
- Burlington, MA (US) (2022)
Company Filing History:
Years Active: 2022
Title: Innovations of Xiaoxi Liu in Cancer Treatment
Introduction
Xiaoxi Liu is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research. He has been instrumental in developing innovative therapies aimed at treating multiple myeloma and other hematologic malignancies. With a total of two patents to his name, Liu's work is paving the way for new treatment options in oncology.
Latest Patents
Liu's latest patents include "USP7 inhibitors for treating multiple myeloma," which focuses on inhibitors of USP7 that are useful in the treatment of cancers and other diseases mediated by USP7. The patent describes a specific formula where various components are detailed for their therapeutic potential. Another notable patent is for "Compounds for the degradation of STK4 and treatment of hematologic malignancies." This application relates to a compound that modulates the amount of STK4, along with a pharmaceutical composition and methods for treating or preventing diseases associated with STK4 modulation.
Career Highlights
Xiaoxi Liu is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in cancer therapies. His work is characterized by a commitment to improving patient outcomes through innovative scientific approaches.
Collaborations
Liu collaborates with esteemed colleagues, including Sara Jean Buhrlage and Kenneth Carl Anderson, who contribute to his research efforts and enhance the impact of his work in the field of cancer treatment.
Conclusion
Xiaoxi Liu's innovative patents and research at the Dana-Farber Cancer Institute Inc. highlight his dedication to advancing cancer treatment. His contributions are vital in the ongoing fight against hematologic malignancies and demonstrate the importance of innovation in medical science.